Pharma Mar reported EUR0.16 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.23 -0.23 Nov/04
FY2026Q2 Jun/2026 -0.06 0.22 1.32 Jul/29
FY2026Q1 Mar/2026 0.28 -0.23 May/29
FY2025Q4 Dec/2025 3.34 0.99 0.99 Mar/02
FY2025Q3 Sep/2025 -0.23 0.28 0.22 Oct/30




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
IQVIA Holdings USD 3.15 0.25 Jun/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Moderna USD -1.97 1.43 Jun/2026
Organon & Co USD 0.71 0.08 Mar/2026
Pharma Mar EUR 0.16 0.07 Jun/2026
Revvity USD 1.41 0.35 Jun/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026